REQUEST A DEMO
Total
USD $0.00
Search more companies

Dt&Cro Co., Ltd. (Yongin) (South Korea)

Main Activities: Scientific Research and Development Services | Research and Development in Nanotechnology
Full name: Dt&Cro Co., Ltd. Profile Updated: November 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a Korea-based company principally engaged in the contract research business. The Company is engaged in the provision of non-clinical and clinical trial services in the fields of pharmaceuticals, medical devices, food, chemicals and cosmetics. The Company is also engaged in the provision of analysis, efficacy evaluation and other services. The Company was established on April 3, 2017. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on Novembe 11, 2022.

Headquarters
28, Baengnyeong-Ro 20Beon-Gil, Cheoin-Gu
Yongin; Gyeonggi;

Contact Details: Purchase the Dt&Cro Co., Ltd. (Yongin) report to view the information.

Website: http://www.dtncro.com

Basic Information
Total Employees:
Purchase the Dt&Cro Co., Ltd. (Yongin) report to view the information.
Outstanding Shares:
Purchase the Dt&Cro Co., Ltd. (Yongin) report to view the information.
Registered Capital:
Purchase the Dt&Cro Co., Ltd. (Yongin) report to view the information.
Incorporation Date:
April 03, 2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after Dt&Cro Co., Ltd. (Yongin) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
34.38%
Total operating revenue
34.38%
Operating profit (EBIT)
7.88%
EBITDA
14.48%
Net Profit (Loss) for the Period
21.44%
Total assets
96.23%
Total equity
157.26%
Operating Profit Margin (ROS)
-2.95%
Net Profit Margin
-1.27%
Return on Equity (ROE)
-12.68%
Debt to Equity Ratio
-13.45%
Quick Ratio
0.87%
Cash Ratio
0.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?